Prospective trial of targeted radioimmunotherapy with Y-90 ibritumomab tiuxetan (Zevalin) for front-line treatment of early-stage extranodal indolent ocular adnexal lymphoma

Authors: Bita Esmaeli, Peter McLaughlin, Barbara Pro, Felipe Samaniego, Isis Gayed, Fredrick B. Hagemeister, Jorge Romaguera, Fernando Cabanillas, Sattva S. Neelapu, R. Banay, Luis Fayad, M. Wayne Saville, Larry W. Kwak - Annals of Oncology 2009 cited by 88